Oncotelic Therapeutics, Inc. Proceeds from Issuance of Private Placement
Oncotelic Therapeutics, Inc. (OTLC) reported Proceeds from Issuance of Private Placement of -$50.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-18.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2023-08-18
- Oncotelic Therapeutics, Inc. proceeds from issuance of private placement for the quarter ending 2022-09-30 was $0.00.
- Oncotelic Therapeutics, Inc. proceeds from issuance of private placement for the quarter ending 2021-12-31 was -$68.15K, a 110.91% decline year-over-year.
- Oncotelic Therapeutics, Inc. proceeds from issuance of private placement for the quarter ending 2021-09-30 was $0.00.
- Oncotelic Therapeutics, Inc. proceeds from issuance of private placement for the quarter ending 2021-06-30 was $0.00.
- Oncotelic Therapeutics, Inc. proceeds from issuance of private placement for fiscal 2021 was $1.55M, a 47.25% decline from fiscal 2020.
- Oncotelic Therapeutics, Inc. proceeds from issuance of private placement for fiscal 2020 was $2.93M.
- Oncotelic Therapeutics, Inc. proceeds from issuance of private placement for fiscal 2012 was $7.50M.
| Period end | Proceeds from Issuance of Private Placement 0 month | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|---|
| 2023-06-30 | -$50.00K 10-Q · filed 2023-08-18 | ||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-18 | -$25.00K 10-Q · filed 2022-11-18 | |||
| 2022-06-30 | -$25.00K 10-Q · filed 2023-08-18 | ||||
| 2021-12-31 | -$68.15K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-04-20 | -$68.15K derived: sum of 2 quarters · filed 2023-04-20 | -$68.15K derived: sum of 3 quarters · filed 2023-04-20 | $1.55M 10-K/A · filed 2023-04-20 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-18 | $0.00 derived: sum of 2 quarters · filed 2022-11-18 | $1.61M 10-Q · filed 2022-11-18 | $2.24M derived: sum of 4 quarters · filed 2022-11-18 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-22 | $1.61M 10-Q · filed 2022-08-22 | $2.24M derived: sum of 3 quarters · filed 2022-08-22 | ||
| 2021-03-31 | $1.61M 10-Q · filed 2021-05-24 | $2.24M derived: sum of 2 quarters · filed 2022-04-15 | |||
| 2020-12-31 | $624.51K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-15 | $2.93M 10-K · filed 2022-04-15 | |||
| 2020-09-30 | $2.30M 10-Q · filed 2021-11-22 | ||||
| 2013-04-24 | $4.19M 10-K · filed 2014-03-20 | ||||
| 2012-12-31 | $7.50M 10-K · filed 2013-03-15 |